Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,431.60    -10.80 (-0.75%)
Bid:
1,428.00
Ask:
1,428.40
Spread: 0.40 (0.028%)
Market Cap: £245.49b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Director Declaration / Subsidiary Board Role

2 Mar 2026 10:00

RNS Number : 9148U
HSBC Holdings PLC
02 March 2026
 

 

2 March 2026

HSBC HOLDINGS PLC

DIRECTOR DECLARATION / SUBSIDIARY BOARD ROLE

 

HSBC Holdings plc ('HSBC' or 'Group') today provides an update on succession for a key subsidiary board role which will further strengthen the alignment and connectivity with the Group.

 

In accordance with the PRA Ring-Fencing Rules, and corporate governance best practice, Dame Clara Furse will retire as non-executive Chair of HSBC UK Bank plc in 1H26 after serving 9 years.

 

In line with HSBC Board's succession planning activity, Dame Carolyn Fairbairn, currently Chair of the HSBC Group Remuneration Committee, will assume the role of non-executive Chair of HSBC UK Bank plc by the end of 1H26, subject to regulatory approval. Dame Carolyn's proposed appointment follows a robust succession process which considered both internal and external candidates.

 

Dame Carolyn brings deep experience of the UK commercial and business environment and as well as the role of UK businesses in an international context. Her customer-oriented perspective, strategic acumen, regulatory expertise and strong stakeholder management experience, make her ideally suited for the role. She will remain an independent non-executive Director of HSBC Holdings plc and Chair of the Group Remuneration Committee.

 

Brendan Nelson, Group Chairman, will step down as an independent non-executive Director of HSBC UK Bank plc, effective from Dame Carolyn's appointment to the HSBC UK board.

 

Group Chairman, Brendan Nelson said:

 

"I would like to thank Dame Clara for her dedication, commitment and the significant contribution she has made to HSBC during her time as Chair of HSBC UK. I believe that Dame Carolyn's deep understanding of the UK business and regulatory landscape will be invaluable in the next phase of delivery of HSBC UK Bank's growth strategy and as we deliver for our investors, customers, communities and employees."

 

For and on behalf of HSBC Holdings plc

Angela McEntee

Group Company Secretary

 

 

 

 

HSBC Holdings plc

Registered Office and Group Head Office:

8 Canada Square, London E14 5HQ, United Kingdom

Web: www.hsbc.com

Incorporated in England and Wales with limited liability. Registration number 617987.

 

Media enquiries to:

Neil Fleming +44 (0) 7384 792051 neil1.fleming@hsbc.com

 

Supplementary Information:

The HSBC Group Board of Directors at the date of this announcement comprises: Brendan Robert Nelson*, Georges Bahjat Elhedery, Geraldine Joyce Buckingham?, Wei Sun Christianson?, Rachel Duan?, Dame Carolyn Julie Fairbairn?, James Anthony Forese?, Ann Frances Godbehere?, Steven Craig Guggenheimer?, Manveen (Pam) Kaur, Dr José Antonio Meade Kuribreña?, Kalpana Jaisingh Morparia?, Eileen K Murray? and Swee Lian Teo?.

* Independent non-executive Chairman

? Independent non-executive Director

 

HSBC Group

HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 56 countries and territories. With assets of US$3.233bn at 31 December 2025, HSBC is one of the world's largest banking and financial services organisations.

HSBC UK Bank plc

HSBC UK serves over 15 million active customers across the UK, supported by 23,800 colleagues. HSBC UK offers a complete range of retail banking and wealth management to personal and private banking customers, as well as commercial banking for small to medium businesses and large corporates. HSBC UK is a ring-fenced bank and wholly-owned subsidiary of HSBC Holdings plc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNUUOKRNKUORRR
Date   Source Headline
18th Jun 20261:04 pmRNSHolding(s) in Company
17th Jun 202610:08 amRNSPre Stabilisation Notice
15th Jun 20264:12 pmRNSHolding(s) in Company
15th Jun 20261:00 pmRNSFirst Interim Dividend for 2026 - Exchange Rate
11th Jun 20265:10 pmRNSNotice of redemption
2nd Jun 20262:41 pmRNSHolding(s) in Company
29th May 20264:01 pmRNSTotal Voting Rights
29th May 20264:00 pmRNSNotification of issuance under block listing
27th May 20264:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSIssuance of senior unsecured notes
21st May 20267:00 amRNSHSBC investor and analyst Asia seminar
20th May 20267:00 amRNSHSBC investor and analyst Asia seminar
18th May 20264:20 pmRNSIssuance of perpetual subordinated CC securities
15th May 202611:00 amRNSNotice of redemption and cancellation of listing
12th May 20264:40 pmRNSIssuance of senior unsecured notes (USD)
12th May 20264:05 pmRNSIssuance of senior unsecured notes
12th May 20267:00 amRNSIssuance of perpetual subordinated CCS
8th May 20262:15 pmRNSResult of AGM
8th May 202610:03 amRNSAGM Statements
7th May 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
6th May 202610:00 amRNSBoard and Committee Composition
5th May 202612:30 pmRNSPublication of base prospectus supplement
5th May 20267:00 amRNSEarnings Release 1Q26 Zoom Meeting
5th May 20267:00 amRNSEarnings Release 1Q26
1st May 20264:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:01 pmRNSTotal Voting Rights
30th Apr 20263:00 pmRNSNotification of issuance under block listing
28th Apr 20269:51 amRNSHolding(s) in Company
23rd Apr 202610:00 amRNSNotice of redemption & cancellation of listing
22nd Apr 202610:00 amRNSOverseas Regulatory Announcement - Board Meeting
20th Apr 202612:45 pmRNSFourth Interim Dividend for 2025 - Exchange Rate
17th Apr 20267:00 amRNSAmended and Restated Notice of Redemption
16th Apr 20262:30 pmRNSNotice of redemption
16th Apr 20269:02 amRNSHolding(s) in Company
14th Apr 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Mar 20265:01 pmRNSTotal Voting Rights
30th Mar 20265:00 pmRNSNotification of issuance under block listing
30th Mar 20264:40 pmRNSPublication of base prospectus
27th Mar 20261:30 pmRNSIssuance of senior unsecured notes
27th Mar 20269:00 amRNS2026 AGM - Documents available at NSM
26th Mar 20264:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:30 amRNSHong Kong Waiver-Contingent Convertible Securities
24th Mar 20264:30 pmRNSDirector/PDMR Shareholding
24th Mar 20263:50 pmRNSIssuance of contingent convertible securities
20th Mar 202611:35 amRNSHolding(s) in Company
20th Mar 202610:56 amRNSHolding(s) in Company
18th Mar 20265:13 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPam Kaur speaks at Investor Conference
18th Mar 20267:00 amRNSIssuance of contingent convertible securities
16th Mar 20269:23 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.